Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams(Vanderbilt University Medical Center), Srilatha Edupuganti(Emory University), Mary Allen(National Institutes of Health), Jonathan D. Fuchs, David B. Weiner(The Wistar Institute), Michael Pensiero(National Institute of Allergy and Infectious Diseases), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Stephen De Rosa(Fred Hutch Cancer Center), Niranjan Y. Sardesai(Io Therapeutics (United States)), Adam Sherwat(National Institute of Allergy and Infectious Diseases), Amir Sada Khan(COMSATS University Islamabad), John H. Eldridge(Profectus Biosciences (United States)), M. Cardinali(National Institute of Allergy and Infectious Diseases), Barbara Metch(Fred Hutch Cancer Center), Denny H. Kim(Astellas Pharma (United States)), Scott Parker(University of Alabama), Beryl A. Koblin(New York Blood Center), Kyle Rybczyk(Vanderbilt University), Ian Frank(Norwegian Womens Public Health Association), Jean Boyer(University of Pennsylvania), Jian Yan(Inovio Pharmaceuticals (United States)), Christopher Butler(University of Oxford), Donald K. Carter(Fred Hutch Cancer Center), Lindsey R. Baden(Brigham and Women's Hospital), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael C. Keefer(University of Rochester Medical Center), Marnie Elizaga(Fred Hutch Cancer Center), Patrice Joseph(Gheskio Centers)

The Journal of Infectious Diseases

July 8, 2013

Cited by 197

|New England Journal of Medicine|2020|1.4k

|Science|2022|1.2k

|Clinical Infectious Diseases|2020|1.1k

|Nature Communications|2020|981

|Clinical Infectious Diseases|2001|969

Related Papers